Structure Therapeutics ... won't be short So on the basis of where the company is today, Structure Therapeutics could indeed become the next Novo Nordisk. The catch is that Structure is still ...

Novo Nordisk announced ... change was the “wish” of the Novo Nordisk Foundation, an independent nonprofit that controls the company—an ownership structure that is common among large Danish ...

Ozempic maker Novo ... that Novo Nordisk would make a change in response to stock-market moves. The company and the Novo foundation have previously touted the unusual ownership structure as ...

Joining the consortium are Bristol Myers Squibb, COGNANO, Lambda, Novo Nordisk ... Design. Structure Therapeutics,headquartered in San Francisco, California, is a biotechnology company focused ...

The runaway success of GLP-1 drugs made Novo Nordisk, a Danish drugmaker, the top company in Europe by market cap. These medications, injected into the body, mimic a hormone that regulates blood ...

LONDON — Lars Fruergaard Jørgensen, who led Novo Nordisk as it rode the boom of ... is stepping down as CEO, the company said Friday. Jørgensen, who’s worked at Novo for more than 30 years ...